Lee's Pharmaceutical Holdings Overview

  • Founded
  • 1994
Founded
  • Status
  • Public
  • Employees
  • 1,354
Employees
  • Stock Symbol
  • 00950
Stock Symbol
  • Investments
  • 6
  • Share Price
  • $0.52
  • (As of Thursday Closing)

Lee's Pharmaceutical Holdings General Information

Description

Lee's Pharmaceutical Holdings Ltd is a Cayman Island-based research-driven and market-oriented biopharmaceutical company. It is integrated with solid infrastructures in drug development, clinical development, regulatory, manufacturing, sales, and marketing in China with global perspectives. It focuses on cardiovascular and infectious diseases, dermatology, oncology, gynecology, ophthalmology, and others. Its portfolio has two categories of Proprietary products and Licensed-in products. Its maximum revenue is generated from China. The Proprietary Products portfolio includes Livaracine, Yallaferon, Eyprotor. And its License-in Products include Carnitene, Ferplex, ALOXI, Zanidip, Dafnegin, Veloderm, Levocarnitine Oral Solution, Remodulin.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Discovery Tools (Healthcare)
Drug Discovery
Stock Exchange
HKG
Primary Office
  • 1/F, Building 20E, Phase 3
  • Hong Kong Science Park
  • Shatin
  • Hong Kong
+852 2314 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Lee's Pharmaceutical Holdings Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.52 $0.52 $0.47 - $0.88 $306M 589M 789K $0.48

Lee's Pharmaceutical Holdings Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 330,458 326,591 277,649 366,274
Revenue 160,386 156,854 155,560 145,146
EBITDA 288,108 33,242 27,027 64,919
Net Income 282,022 16,671 16,023 53,365
Total Assets 594,490 419,605 467,381 383,853
Total Debt 22,854 20,214 21,563 16,709
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Lee's Pharmaceutical Holdings Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Lee's Pharmaceutical Holdings‘s full profile, request access.

Request a free trial

Lee's Pharmaceutical Holdings Executive Team (4)

Name Title Board Seat Contact Info
Xiaoyi Li Ph.D Chief Executive Officer & Chief Technology Officer
Yueshen Chen Chief Operating Officer
Wanee Leelalertsuphakun Managing Director & Chief Marketing & Sales Officer
You’re viewing 3 of 4 executive team members. Get the full list »

Lee's Pharmaceutical Holdings Board Members (5)

Name Representing Role Since
Chan Yau Ching Self Board Member 000 0000
Lam Yat Cheong Self Board Member 000 0000
Lee Fong Lee's Pharmaceutical Holdings Executive Chairman 000 0000
Tsim Wah Keung Self Board Member 000 0000
You’re viewing 4 of 5 board members. Get the full list »

Lee's Pharmaceutical Holdings Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lee's Pharmaceutical Holdings Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Lee's Pharmaceutical Holdings‘s full profile, request access.

Request a free trial

Lee's Pharmaceutical Holdings Investments & Acquisitions (6)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 00000000000 30-Oct-2020 00000 00000 00 00000 Pharmaceuticals
00000000 000000000 04-Apr-2018 0000 000.00 Biotechnology
00000000 000000000 01-Nov-2017 000000000000000000 0000 Biotechnology 00000000 00 00.0
0000000 27-Sep-2016 00000 00000 00 00.000 Drug Discovery
EyeSense 27-Nov-2014 Later Stage VC Monitoring Equipment 00000000 00 00.0
You’re viewing 5 of 6 investments and acquisitions. Get the full list »

Lee's Pharmaceutical Holdings Subsidiaries (3)

Company Name Industry Location Founded
China Ophthalmology Focus Pharmaceuticals Guangdong, China 2017
0000 000000000000 Drug Discovery Taipei, Taiwan 0000
00000000 000000000 Biotechnology Warrington, PA 0000
To view Lee's Pharmaceutical Holdings’s complete subsidiaries history, request access »

Lee's Pharmaceutical Holdings Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 00000000000 30-Oct-2020 00000 00000 00 00000 Completed
  • 12 buyers
CVie Therapeutics Company 07-Aug-2012 Joint Venture Completed
To view Lee's Pharmaceutical Holdings’s complete exits history, request access »